id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1993-N-0150-0006,FDA,FDA-1993-N-0150,"Transcript of Proceedings for the Financial Disclosure by Clinical Investigators (July 20, 1995)",Other,TR-Transcript,2011-02-17T05:00:00Z,2011,2,2011-02-17T05:00:00Z,,2011-02-17T20:49:08Z,,0,0,09000064804ff2c7
FDA-1993-N-0150-0007,FDA,FDA-1993-N-0150,"FDA Science Board Meeting (March 29, 1996) - Transcript",Other,TR-Transcript,2011-02-17T05:00:00Z,2011,2,2011-02-17T05:00:00Z,,2011-02-17T20:49:51Z,,0,0,09000064804ff2ce
FDA-1993-N-0150-0003,FDA,FDA-1993-N-0150,Financial Disclosure by Clinical Investigators; Correction,Proposed Rule,NCR-Notice of Correction,2010-07-27T04:00:00Z,2010,7,2010-07-27T04:00:00Z,,2010-09-21T01:20:54Z,,0,0,09000064804ff280
FDA-1993-N-0150-0002,FDA,FDA-1993-N-0150,Financial Disclosure by Clinical Investigators; Correction,Rule,NCR-Notice of Correction,2010-07-27T04:00:00Z,2010,7,2010-07-27T04:00:00Z,,2010-07-27T20:52:38Z,,0,0,09000064804ff2da
FDA-1993-N-0150-0004,FDA,FDA-1993-N-0150,Financial Disclosure by Clinical Investigator; Reopening of Comment Period and Notice of Meeting,Proposed Rule,NEC-Notice of Extension,2010-07-27T04:00:00Z,2010,7,2010-07-27T04:00:00Z,1996-04-30T03:59:59Z,2010-07-27T20:55:06Z,,0,0,09000064804ff2cc
FDA-1993-N-0150-0001,FDA,FDA-1993-N-0150,Financial Disclosure By Clinical Investigators,Proposed Rule,NPR-Notice of Proposed Rule-Making,2010-06-07T04:00:00Z,2010,6,2010-06-07T04:00:00Z,1994-12-22T04:59:59Z,2010-10-29T01:01:22Z,,0,0,09000064804ff27a